Doryx Mpc Tablet, Delayed Release
Product Images NDC 51862-560

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Doryx Mpc (NDC 51862-560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dorxy 01)

FDA Label Image

Principal Display Panel (60 mg Tablet Bottle Label)

Principal Display Panel (60 mg Tablet Bottle Label)
This is a description of the medication called Doryx® MPC. Each tablet contains doxycycline, with a dosage equivalent to doxycycline hyclate 138.8 mg. The recommended dosage can be found in the package insert. It is important to keep this medication away from children and store at a temperature of 25°C, with excursions allowed between 15-30°C. The medication should be dispensed in a tight, light-resistant container. Doryx® MPC is distributed by Mayne Pharma in Greenville, NC, and is a product of Macau. The tablets come in a pack of 30, each tablet containing 120mg of doxycycline hyclate. It is advised not to chew or crush the tablets. This medication requires a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.